Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -50.8% | -574.3% | 1 / 3 | +178.9% | +1.54 pp | -1.36 pp | +21.7% | 0.06 | 1.16 | 116 | +178,9% | 3,3 | +89,4% | 1.16 | 26.53 | −95,6% |
| Pts | 0 | 0 | 4 | 12 | 8 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 6.300 (close price on 2026-10-12)EPS (TTM): 5.453
Financial charts
1.Revenue & growth
VND bn116Q2/26
1.Revenue & growth
VND bn116Q2/26
2.Profit & growth
VND bn1,73Q2/26
3.Profit mix (Penman)
VND bn46,7Q2/26
4.Margins & cost structure
%17.9%Q2/26
5.Returns & cash cycle
% · days27.4%Q2/26
6.Earnings quality & cash
VND bn-108Q2/26
7.Asset structure
VND bn308Q2/26
8.Funding & debt health
VND bn · times308Q2/26
9.Revenue backlog
VND bn1,85Q2/26
10.Valuation
times · %2,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %144Q2/26
Adjusted EPS growth, latest quarter
-50.8%
Average adjusted EPS growth, 3 quarters
-574%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
100%
Source: vnstockData through Q2/26